Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study.

Ceccarelli G, Borrazzo C, Lazzaro A, Innocenti GP, Celani L, Cavallari EN, Pinacchio C, Santinelli L, Mastroianni CM, d'Ettorre G.

Brain Sci. 2019 Oct 17;9(10). pii: E278. doi: 10.3390/brainsci9100278.

2.

BioTimer assay as complementary method to vortex-sonication-vortex technique for the microbiological diagnosis of implant associated infections.

Rosa L, Lepanto MS, Cutone A, Berlutti F, De Angelis M, Vullo V, Mastroianni CM, Valenti P, Oliva A.

Sci Rep. 2019 May 17;9(1):7534. doi: 10.1038/s41598-019-44045-1.

3.

Physical Activity and HIV: Effects on Fitness Status, Metabolism, Inflammation and Immune-Activation.

Ceccarelli G, Pinacchio C, Santinelli L, Adami PE, Borrazzo C, Cavallari EN, Vullo A, Innocenti GP, Mezzaroma I, Mastroianni CM, d'Ettorre G.

AIDS Behav. 2019 Apr 23. doi: 10.1007/s10461-019-02510-y. [Epub ahead of print]

PMID:
31016505
4.

Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice.

Alteri C, Scutari R, Bertoli A, Armenia D, Gori C, Fabbri G, Mastroianni CM, Cerva C, Cristaudo A, Vicenti I, Bruzzone B, Zazzi M, Andreoni M, Antinori A, Svicher V, Ceccherini-Silberstein F, Perno CF, Santoro MM.

Virus Genes. 2019 Jun;55(3):290-297. doi: 10.1007/s11262-019-01649-z. Epub 2019 Feb 22.

PMID:
30796743
5.

Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients.

Iannetta M, Zingaropoli MA, Latronico T, Pati I, Pontecorvo S, Prezioso C, Pietropaolo V, Cortese A, Frontoni M, D'Agostino C, Francia A, Vullo V, Mastroianni CM, Liuzzi GM, Ciardi MR.

Sci Rep. 2019 Jan 22;9(1):311. doi: 10.1038/s41598-018-36535-5.

6.

Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters.

Iannetta M, Savinelli S, Rossi R, Mascia C, Marocco R, Vita S, Zuccalà P, Zingaropoli MA, Mengoni F, Massetti AP, Falciano M, d'Ettorre G, Ciardi MR, Mastroianni CM, Vullo V, Lichtner M.

Immunobiology. 2019 Mar;224(2):231-241. doi: 10.1016/j.imbio.2018.11.011. Epub 2018 Nov 28.

PMID:
30522891
7.

Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.

Bassetti M, Castaldo N, Cattelan A, Mussini C, Righi E, Tascini C, Menichetti F, Mastroianni CM, Tumbarello M, Grossi P, Artioli S, Carannante N, Cipriani L, Coletto D, Russo A, Digaetano M, Losito AR, Peghin M, Capone A, Nicolè S, Vena A; CEFTABUSE Study Group.

Int J Antimicrob Agents. 2019 Apr;53(4):408-415. doi: 10.1016/j.ijantimicag.2018.11.001. Epub 2018 Nov 8.

PMID:
30415002
8.

Genetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalence.

Alteri C, Fabeni L, Scutari R, Berno G, Di Carlo D, Gori C, Bertoli A, Vergori A, Mastrorosa I, Bellagamba R, Mussini C, Colafigli M, Montella F, Pennica A, Mastroianni CM, Girardi E, Andreoni M, Antinori A, Svicher V, Ceccherini-Silberstein F, Perno CF, Santoro MM.

Sci Rep. 2018 Oct 24;8(1):15739. doi: 10.1038/s41598-018-34058-7.

9.

Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: A case report.

Caraffa E, Russo G, Vita S, Lichtner M, Massetti AP, Mastroianni CM, Vullo V, Ciardi MR, Ajassa C.

Medicine (Baltimore). 2018 Jul;97(29):e11186. doi: 10.1097/MD.0000000000011186.

10.

Detection of Biofilm-associated Implant Pathogens in Cardiac Device Infections: High Sensitivity of Sonication Fluid Culture Even in the Presence of Antimicrobials.

Oliva A, Mascellino MT, Nguyen BL, De Angelis M, Cipolla A, Di Berardino A, Ciccaglioni A, Mastroianni CM, Vullo V.

J Glob Infect Dis. 2018 Apr-Jun;10(2):74-79. doi: 10.4103/jgid.jgid_31_17.

11.

Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.

Ascione A, De Luca M, Melazzini M, Montilla S, Trotta MP, Petta S, Puoti M, Sangiovanni V, Messina V, Bruno S, Izzi A, Villa E, Aghemo A, Zignego AL, Orlandini A, Fontanella L, Gasbarrini A, Marzioni M, Giannini EG, Craxì A; ABACUS Study Group.

Infection. 2018 Oct;46(5):607-615. doi: 10.1007/s15010-018-1157-x. Epub 2018 May 28.

PMID:
29808463
12.

Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection.

Mascia C, Pozzetto I, Kertusha B, Marocco R, Del Borgo C, Tieghi T, Vita S, Savinelli S, Iannetta M, Vullo V, Lichtner M, Mastroianni CM.

PLoS One. 2018 May 24;13(5):e0198174. doi: 10.1371/journal.pone.0198174. eCollection 2018.

13.

Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases.

Sauzullo I, Scrivo R, Sessa P, Mengoni F, Vullo V, Valesini G, Mastroianni CM.

Sci Rep. 2018 May 18;8(1):7881. doi: 10.1038/s41598-018-26097-x.

14.

Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment.

Armenia D, Zaccarelli M, Borghi V, Gennari W, Di Carlo D, Giannetti A, Forbici F, Bertoli A, Gori C, Fabeni L, Pinnetti C, Marocco R, Latini A, Ceccherini-Silberstein F, Mastroianni CM, Mussini C, Antinori A, Perno CF, Santoro MM.

J Clin Virol. 2018 Jul;104:61-64. doi: 10.1016/j.jcv.2018.04.001. Epub 2018 Apr 3.

PMID:
29738896
15.

Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs).

Pavone P, Alfieri G, Corano-Scheri G, Pinacchio C, Fard SN, Mascia C, Tieghi T, Lichtner M, d'Ettorre G, Vullo V, Mastroianni CM.

Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):e45-e48. doi: 10.1016/j.clinre.2018.02.004. Epub 2018 May 4. No abstract available.

PMID:
29735250
16.

In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition.

Latronico T, Pati I, Ciavarella R, Fasano A, Mengoni F, Lichtner M, Vullo V, Mastroianni CM, Liuzzi GM.

J Neurochem. 2018 Feb;144(3):271-284. doi: 10.1111/jnc.14269. Epub 2018 Jan 9.

17.

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains.

Fabeni L, Berno G, Fokam J, Bertoli A, Alteri C, Gori C, Forbici F, Takou D, Vergori A, Zaccarelli M, Maffongelli G, Borghi V, Latini A, Pennica A, Mastroianni CM, Montella F, Mussini C, Andreoni M, Antinori A, Perno CF, Santoro MM; Resistance Study Group.

J Clin Microbiol. 2017 Sep;55(9):2827-2837. doi: 10.1128/JCM.00656-17. Epub 2017 Jul 12.

18.

Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia.

Oliva A, Cipolla A, Vullo V, Venditti M, Mastroianni CM, Falcone M.

New Microbiol. 2017 Jul;40(3):205-207. Epub 2017 Jul 4.

19.

Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon.

Mascia C, Vita S, Zuccalà P, Marocco R, Tieghi T, Savinelli S, Rossi R, Iannetta M, Pozzetto I, Furlan C, Mengoni F, Mastroianni CM, Vullo V, Lichtner M.

PLoS One. 2017 Jun 21;12(6):e0179400. doi: 10.1371/journal.pone.0179400. eCollection 2017.

20.

Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.

Mascia C, Lichtner M, Zuccalà P, Vita S, Tieghi T, Marocco R, Savinelli S, Rossi R, Iannetta M, Campagna M, Schiavone F, Mengoni F, Russo G, Mastroianni CM, Vullo V.

Clin Res Hepatol Gastroenterol. 2017 Dec;41(6):644-655. doi: 10.1016/j.clinre.2017.04.007. Epub 2017 May 31.

PMID:
28578937

Supplemental Content

Loading ...
Support Center